Phytocannabinoids in triple negative breast cancer treatment: current knowledge and future insights

S Bimonte, G Palma, M Cascella… - Anticancer Research, 2023 - ar.iiarjournals.org
Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …
被引用次数：9 相关文章
[PDF] archive.org

[PDF][PDF] Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights

S BIMONTE, G PALMA, M CASCELLA… - ANTICANCER …, 2023 - scholar.archive.org
Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …

Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights

S Bimonte, G Palma, M Cascella… - Anticancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …

Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights.

S Bimonte, G Palma, M Cascella, A Cuomo - Anticancer Research, 2023 - europepmc.org
Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …

Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights

S Bimonte, G Palma, M Cascella, A Cuomo - ANTICANCER RESEARCH, 2023 - iris.unisa.it
Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …

Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights

S BIMONTE, G PALMA, M CASCELLA… - ANTICANCER …, 2023 - ar.iiarjournals.org
Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …